Patent · US Active

Mutated HIV Nef for modulating immunity

US8795685B2 · kind B2 · utility

2Cited by

4References

7Claims

0Family size

Assignees

INSTITUT GUSTAVE ROUSSY · FR
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE · FR
UNIVERSITÉ PARIS CITÉ · FR

Inventors

Martial Renard · Paris, FR
Marianne Mangeney · Paris, FR
Thierry Heidmann · Paris, FR

Key dates

Filing date	Aug 17, 2005
Grant date	Aug 5, 2014
Priority date	—
Expiry date	Jun 6, 2029

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/163
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described is the use of a mutation of at least one amino acid in the immunosuppressive domain of a HIV or SIV accessory protein, for modulating the immunosuppressive property of the protein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.